ArticleCureus2024
Unexpected Discrepancies in the Histopathological and Microbiological Diagnoses of Suspected Mucormycosis Cases at a South Indian Tertiary Care Center During the COVID-19 Pandemic.
Article in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Automated Mucormycosis Diagnosis from Paranasal CT Using ResNet50 and ConvNeXt Small.Bioengineering (Basel, Switzerland) · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction Mucormycosis is an uncommon fungal infection caused by filamentous fungi of the Mucorales order, namely Rhizopus, Lichthemia, andMucor species. The incidence and prevalence of mucormycosis reached an all-time high during the COVID-19 pandemic due to excessive steroid use and other factors, leading to the coining of the term CAM (COVID Associated Mucormycosis). The diagnosis of mucormycosis is by a combination of histopathology and microbiological techniques, such as KOH mount and culture. Although microbiological and histopathological findings usually correlate, certain discrepancies are known to occur and are discussed in our study. The aim of our research is to study the correlation between histopathology and microbiology findings, as well as their respective merits and limitations, in suspected mucormycosis cases in COVID-19 patients at a tertiary healthcare center in South India. Methods It is a retrospective study, where data from 74 COVID-19 patients admitted in the ENT ward between June 2021 and August 2021 with a suspicion of mucormycosis was collected. Samples from these patients were sent to the pathology and microbiology departments of Rangaraya Medical College. KOH mount, culture on Saboraud's Dextrose Agar (SDA), and histopathology findings were analyzed. Results Histopathology and culture findings of Mucormycosis were correlated in 64 isolates (86.5%), including five cases (6.7%) of mixed infections, where the culture was positive for only a single type of fungus. In the remaining 10 isolates, discrepancies were observed, accounting for 13.5% of the total sample size. Pearson's correlation coefficient test did not reveal any statistically significant correlation in the case of histopathology and microbiology culture or KOH mount, further highlighting the presence of discrepancies. The high correlation between KOH mount and culture isolates (100%) in our study is attributable to the processing of the same sample by the microbiology department. On the other hand, the correlation between histopathology and culture in our study is 86.5%, and the expected correlation as suggested by previous studies is only 50%. These discrepancies between culture and histopathology could be due to different samples being sent to the two departments. Conclusion Although fungal cultures are considered the gold standard, they have drawbacks such as slow growth, and the potential for both false positives and false negatives. KOH mount is a rapid and cost-effective method, but it lacks specificity and sensitivity. Histopathology offers the advantage of specific species identification and assessment of tissue inflammation; however, it is an invasive procedure and poses challenges in accurately identifying the fungus. A multidisciplinary approach, with coordination between physicians, surgeons, pathologists, clinical microbiologists, and radiologists, is essential for timely diagnosis and management. For accurate identification of the causative organism, it is recommended to send the same sample for histopathological examination, KOH mount, and culture.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.